Synarc is one of the world's largest Central Radiology service dedicated exclusively to global clinical trials. Synarc's in-house radiologists and scientists are leading authorities in the use of medical imaging and molecular markers in drug development, and have pioneered many methods currently used in clinical trials. With eight offices around the world, the company currently manages over 150 clinical trials, involving more than 60,000 patients at 1,500 sites worldwide. Its services integrate all aspects of the design and execution of medical imaging and molecular markers in clinical trials across a spectrum of diseases including Oncology, Arthritis, Osteoporosis, Neurology, Orthopedics and Cardiovascular disease. The company has eight offices around the world including San Francisco; Boston; Portland, Ore.; Hamburg, Germany; Copenhagen, Denmark; Lyon, France; Paris and Beijing.